Details
Category: Volume 05 Issue 11 November 2017
Hits: 1625

Title: Prevalence of Microalbuminuria in Patients with Type 2 Diabetes Mellitus

Authors: Dr Shahul Hameed MM, Dr Ambili NR, Rashmi KP

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i11.25

Abstract

Diabetes Mellitus has become the most prevalent endocrine disorder in recent times and associated with myriad metabolic, microvascular and macrovascular complications. India has the world’s largest Diabetes population and the disease has significant morbidity and mortality. It has become one of the leading causes of acquired blindness and accounts for at-least a quarter of cases of end stage renal disease. Being a clinically silent disease, early recognition is vital to prevent visual loss. Numerous studies carried out to determine the prevalence rate of retinopathy and albuminuria in patients with type 2 diabetes have yielded different rates, thus depicting the ethnic influence. This cross-sectional study was carried out on 300 type 2 diabetic patients attending the OPD of Department of Internal Medicine in Govt T D Medical college, Allappuzha during 2012-13. In our study, prevalence of micro-albuminuria was 23% with a higher incidence in those with longer duration of diabetes, higher age and higher BMI. Further, a significant positive association was found between micro-albuminuria and retinopathy and a negative association with HDL. This study concluded that there is justification in focussing resources on early detection of microalbuminuria in order to prevent irreversible visual and renal afflictions.

References

  1. Thomas H Hostetter: “Diabetic nephropathy” Chapter 34; The Kidney, Brenner and Rector (Eds) IV Edn, VolI, Philadelphia, WB Saunders Company;1991: 1695-1719.
  2. Wild S, Roglic G, Green A. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 24(5): 1047-53.
  3. Mohan V: Epidemiology of Type 2 Diabetes: Indian scenario. Indian Med Res 2007; 125: 217-230.
  4. Unwin N, Whiting D Gan D et al. Editors. IDF Diabetes atlas.4th Brussels (Belgium): International Diabetes Foundation ;2009:22-9. Chapter 2.1.1
  5. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E: “Microalbuminuria; An early marker of renal involvement in diabetes”;2008: 112-117.
  6. “Diabetic Nephropathy” Clinical practice recommendations, American Diabetes Association, 2010:201-210.
  7. Stratton IM, Adler AI, Neil HA, Mathews DR, Manley SE Cull CA et al. Association of glycemia with microvascular and macrovascular complications of type 2 diabetes. (UKPDS35); prospective observational study. BMJ 2000; 321:405.
  8. Hans- Hernik Parving , EVA Hommel, Elisabeth Mathiesen, Peter Skott, Beirt Edsbeerg. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes mellitus. Br Med J 1988; 4: 99-103.
  9. 2nd Annual Report CKD Registry of Indian. Indian Society of Nephrology. Uremia Investig 1985-86; 9: 85-95.
  10. Stratton IM, Adler AI, Neil HA, Mathews DR, Manley SE, Cull CA et al. Associa-tion of glycemia with macrovascular and microvascular complications of type 2 Diabetes (UKPDS 35): prospective observational study .BMJ 2000; 321:405.
  11. Nettelstup EN. Chronic retinitis in diabetes. Trans Opthal Soc UK 1888; 8: 159-162.
  12. Mogensen CE, Maurer SM, Kjellstraud CM: Diabetic Nephropathy. Chapter 79 in Disease of the Kidney, IV Edn, SChrier RW, Gottschalk WC.(Eds) VolII 1998.
  13. Gaede PH, Vedel P, Larsen N, Jenesen GV, Parving HH, Penederson O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes mellitus. N Eng J Med. 2003; 348: 383-393.
  14. Seymour R, Levin , Jack W Coburn, Carlos Abraira, William G Henderson, John A Colwell, Nicholas V Emmanuel. Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Diabetes Care, 2000; 23(10): 1479-1485.
  15. Durutty P, Diaz S , Zanetti L, De La Varas MA, Garcia de los. Microalbuminuria, lipid changes and coronary heart disease in non-insulin dependent diabetes. Revista Medica de Chile, 1998: 126(12); 1425-33.
  16. Chakravarthy B, Taneja V, Sircar S, Kansra U. Microalbuminuria: association with dyslipidemia in non-insulin dependent diabetes mellitus. API, 1997; 45(8): 608-11.
  17. Masoud RM, Afkhami M, Shoja MR: Retinopathy and microalbuminuria in type 2 diabetes patients. BMC Opthalmology.2003; 4: 9.
  18. Wendy PB, Palmisano J, Keane WF. Dyslipidemia in patients with type 2 diabetes mellitus: Relationship between lipids, kidney disease and cardiovascular disease. Clin Chem Lab Med.2003; 41; 9: 1174-1181.
  19. Patel KL, Mhetras SB, Varthakavi PK, Merchant PC, Nihalini KD. Microalbuminuria in non-insulin dependent diabetes mellitus. JAPI, 1999; 47(5): 596-601.
  20. Taneja V, Sircar S, Kansra U, Lamba IMS: Microalbuminuria in normotensive non-insulin dependent diabetic sunjects- associations and predictions. Diab Assoc India, 1997; 37(2): 30-36.
  21. Ghai R, Verma NDS, Goel A. Microalbuminuria in NIIDM and essential Hypertension as a marker of severe disease. JAPI, 1994; 42(10): 771-774.

Corresponding Author

Dr Ambili NR 

Assistant Professor of Medicine, Dept of Medicine,

Govt T D Medical College, Alappuzha